marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Enveric Biosciences Cash Flow 2011-2024 | ENVB
Annual Cash Flow Enveric Biosciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-17.1 M | -11.5 M | -3.89 M | -648 K | -2.57 M | -2.74 M | -2.7 M | -3.9 M | -43.2 K | -21.6 K | -24.8 K | -30.3 K |
Depreciation & Amortization |
328 K | 657 K | 121 K | 2.27 M | 2.9 M | 3.22 M | 1.36 M | 166 K | 116 | - | - | - |
Accounts Payables |
463 K | 683 K | 681 K | 4.7 M | 4.38 M | 5.32 M | 5.13 M | 2.6 M | 8.96 K | 22.7 K | 17.7 K | - |
Accounts Receivables |
- | - | - | 6.38 M | 7.87 M | 8.84 M | 8.06 M | 4.87 M | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Enveric Biosciences
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -5.14 M | - | -13.7 M | -9.13 M | -4.55 M | - | -7.39 M | -5.18 M | -3.16 M | - | -1.64 M | -1.25 M | -894 K | - | -2.45 M | -2.45 M | -984 K | - | -1.56 M | -279 K | -460 K | - | -1.8 M | -1.7 M | -838 K | - | -3 M | -166 K | -1.57 M | - | -4.32 M | -842 K | -331 K | - | - | 233 K | 233 K | - | -21.2 K | -16 K | -12.2 K | - | -21.1 K | -16 K | -12.1 K | - | -25.6 K | -21.9 K | -17 K |
Depreciation & Amortization |
84.8 K | 84.8 K | - | 86.3 K | 86.5 K | 86.5 K | - | 86.6 K | 85.5 K | 69.3 K | - | 174 K | 174 K | 137 K | - | 556 K | 534 K | 560 K | - | 562 K | 563 K | 561 K | - | 636 K | 809 K | 821 K | - | 817 K | 826 K | 689 K | - | 509 K | 101 K | 112 K | - | 9.38 K | 8.05 K | 8.27 K | - | - | 8.57 K | 8.57 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
576 K | 460 K | 1.22 M | 1.1 M | 1.23 M | 1.79 M | 463 K | 710 K | 754 K | - | 683 K | 2.16 M | 1.02 M | 627 K | 681 K | 4.58 M | 4.87 M | 5.25 M | 4.7 M | 4.71 M | 4.7 M | 4.7 M | 4.38 M | 4.38 M | 4.38 M | 4.38 M | 5.32 M | 5.32 M | 5.32 M | 5.32 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 8.96 K | 2.3 K | 2 K | 2.8 M | 22.7 K | 22.7 K | 22.7 K | 22.7 K | 17.7 K | 17.7 K | 17.7 K | 17.7 K | 17.9 K | 7.7 K | 7.7 K | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.56 M | 7.29 M | 8.1 M | 6.38 M | 7.61 M | 6.38 M | 6.38 M | 7.87 M | 7.87 M | 7.87 M | 7.87 M | 8.84 M | 8.84 M | 8.84 M | 8.84 M | 8.06 M | 8.06 M | 8.06 M | 8.06 M | 4.87 M | 4.87 M | 4.87 M | 4.87 M | - | - | - | 2.94 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency